<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Dev Biol</journal-id><journal-title>BMC Developmental Biology</journal-title><issn pub-type="epub">1471-213X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-213X-6-19</article-id><article-id pub-id-type="pmid">16611361</article-id><article-id pub-id-type="doi">10.1186/1471-213X-6-19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Methodology Article</subject></subj-group></article-categories><title-group><article-title>Generation of mice harbouring a conditional loss-of-function allele of <italic>Gata6</italic></article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Sodhi</surname><given-names>Chhinder P</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>csodhi@mcw.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Li</surname><given-names>Jixuan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jxnli@mcw.edu</email></contrib><contrib id="A3" corresp="yes" contrib-type="author"><name><surname>Duncan</surname><given-names>Stephen A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>duncans@mcw.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Cell Biology, Neurobiology &#x00026; Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>12</day><month>4</month><year>2006</year></pub-date><volume>6</volume><fpage>19</fpage><lpage>19</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-213X/6/19"/><history><date date-type="received"><day>26</day><month>1</month><year>2006</year></date><date date-type="accepted"><day>12</day><month>4</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Sodhi et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Sodhi et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Sodhi
               P
               Chhinder
               
               csodhi@mcw.edu
            </dc:author><dc:title>
            Generation of mice harbouring a conditional loss-of-function allele of Gata6
         </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Developmental Biology 6(1): 19-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-213X(2006)6:1&#x0003c;19&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-213X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><p>The zinc finger transcription factor GATA6 is believed to have important roles in the development of several organs including the liver, gastrointestinal tract and heart. However, analyses of the contribution of GATA6 toward organogenesis have been hampered because <italic>Gata6</italic><sup>-/- </sup>mice fail to develop beyond gastrulation due to defects in extraembryonic endoderm function. We have therefore generated a mouse line harbouring a conditional loss-of-function allele of <italic>Gata6 </italic>using <italic>Cre</italic>/<italic>lox</italic>P technology.</p><p><italic>LoxP </italic>elements were introduced into introns flanking exon 2 of the <italic>Gata6 </italic>gene by homologous recombination in ES cells. Mice containing this altered allele were bred to homozygosity and were found to be viable and fertile. To assess the functional integrity of the <italic>loxP </italic>sites and to confirm that we had generated a <italic>Gata6 </italic>loss-of-function allele, we bred <italic>Gata6 </italic>'floxed' mice to <italic>EIIa-Cre </italic>mice in which Cre is ubiquitously expressed, and to <italic>Villin-Cre </italic>mice that express Cre in the epithelial cells of the intestine. We conclude that we have generated a line of mice in which GATA6 activity can be ablated in a cell type specific manner by expression of Cre recombinase. This line of mice can be used to establish the role of GATA6 in regulating embryonic development and various aspects of mammalian physiology.</p></abstract></article-meta></front><body><sec><title>Background</title><p>The mouse <italic>Gata6 </italic>gene encodes a 45 kD protein containing two highly conserved zinc-finger DNA binding domains with a Cys-X<sub>2</sub>-Cys-X<sub>17</sub>-Cys-X<sub>2</sub>-Cys motif that directs binding to the nucleotide sequence element (A/T)GATA(A/G) <xref ref-type="bibr" rid="B1">1</xref>. GATA4, 5 and 6 make up a subset of GATA factors that have been implicated in the development of several organs including the heart, lung, gastrointestinal tract and liver [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. Development of GATA6 null embryos arrests during gastrulation as a consequence of defects in extraembryonic endoderm function [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. This early embryonic lethality can be rescued by complementing the GATA6 null embryos with a wild type extraembryonic visceral endoderm using tetraploid embryo complementation, and embryos derived by this process can survive until E10.5 [<xref ref-type="bibr" rid="B3">3</xref>]. Analyses of such <italic>Gata6</italic><sup>-/-</sup>ES cell-derived embryos has revealed defects in hepatogenesis, which supports the proposal that GATA6 is an important developmental regulator. Although the ability to generate embryos from <italic>Gata6</italic><sup>-/-</sup>ES cells by tetraploid embryo complementation has provided important insight into the contribution of GATA6 during early embryogenesis, this approach is not compatible with studying the role of GATA6 at later stages in development or its role in controlling differentiation of specific cell types. In the current report, we describe the generation of mice containing a conditional null allele of <italic>Gata6 </italic>that can be used for cell type-specific removal of GATA6 by Cre-mediated recombination.</p></sec><sec><title>Results and discussion</title><p>To ensure the elimination of GATA6 activity, we chose to flank <italic>Gata6 </italic>exon 2 (based on nomenclature described by Brewer <italic>et al </italic>[<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]) with <italic>lox</italic>P elements because this exon encodes the majority of the GATA6 protein (Fig. <xref ref-type="fig" rid="F1">1A</xref>). We decided to use a recombineering approach to facilitate the accurate placement of the <italic>lox</italic>P elements following the procedure described by Lee <italic>et al </italic>[<xref ref-type="bibr" rid="B8">8</xref>]. The final targeting vector contained a <italic>lox</italic>P element located between exons 2 and 3. In addition, a cassette containing a <italic>lox</italic>P element lying immediately 5' to a <italic>neomycin phosphotransferase </italic>(<italic>neo</italic>) gene, which conferred resistance to G418, was introduced between exons 1 and 2 (Fig. <xref ref-type="fig" rid="F1">1A</xref>). FRT sites flanked the <italic>neo </italic>gene, in order to allow removal of <italic>neo </italic>by Flp recombinase. Two novel restriction endonuclease cleavage sites (<italic>Eco</italic>RI and <italic>Pac</italic>I) were also introduced into the <italic>Gata6 </italic>targeting vector to allow the identification of correctly modified <italic>Gata6 </italic>alleles by Southern blot analyses. The targeting vector was introduced into R1 ES cells [<xref ref-type="bibr" rid="B9">9</xref>] by electroporation, and G418-resistant ES cell clones were tested for homologous recombination at the <italic>Gata6 </italic>locus by Southern blot analysis. Fig. <xref ref-type="fig" rid="F1">1B</xref> shows an example of a correctly targeted ES (<italic>Gata6</italic><sup><italic>loxP</italic>(<italic>FRTneoFRT</italic>)/+</sup>) cell line. Following digestion of ES cell genomic DNA with <italic>Eco</italic>RI, a probe that lies 3' to the short arm of homology used in the targeting vector identified an expected 8.1 kb wild type <italic>Gata6 </italic>DNA fragment, while correctly targeted cells contain an additional 3.2 kb fragment due to the introduction of a new <italic>Eco</italic>RI site. When <italic>Nde</italic>I digested DNA was probed with a DNA fragment lying 5' to the expected position of the introduced <italic>lox</italic>P site, it identified the predicted 13.2 kb wild type fragment and a novel 15.2 kb fragment, which resulted from introducing the <italic>neo </italic>cassette into the <italic>Gata6 </italic>locus. Five correctly targeted ES cell clones were recovered and three of these cell lines were used to generate chimeric mice by morula aggregation [<xref ref-type="bibr" rid="B10">10</xref>]. These chimeric animals were then mated with CD-1 mice and successful germline transmission of the <italic>Gata6</italic><sup><italic>loxP</italic>(<italic>FRTneoFRT</italic>) </sup>allele was confirmed by Southern blot analysis of tail DNA (Fig. <xref ref-type="fig" rid="F1">1B</xref>). Mice carrying a single <italic>Gata6</italic><sup><italic>loxP</italic>(<italic>FRTneoFRT</italic>)/+ </sup>allele were viable and fertile. However, we were unable to obtain mice that were homozygous for this allele, which suggested that the inclusion of the <italic>neo </italic>cassette disrupted GATA6 function and resulted in embryonic lethality as observed for <italic>Gata6</italic><sup>-/- </sup>embryos [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. We therefore established a mouse line, <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup>, that lacked the <italic>neo </italic>cassette by inducing recombination between the <italic>FRT </italic>sites <italic>in vivo </italic>[<xref ref-type="bibr" rid="B11">11</xref>]. This was achieved by mating <italic>Gata6</italic><sup><italic>loxP</italic>(<italic>FRTneoFRT</italic>)/+ </sup>mice to a transgenic mouse, B6;SJL-Tg(ACTFLPe)9205Dym/J, in which Flp recombinase is widely expressed from the human <italic>beta actin </italic>gene promoter [<xref ref-type="bibr" rid="B11">11</xref>]. Correct excision of the <italic>neo </italic>cassette was confirmed in offspring by Southern blot and PCR analyses (Fig. <xref ref-type="fig" rid="F1">1B</xref> &#x00026; C). <italic>Gata6</italic><sup><italic>loxP</italic>/+ </sup>mice were finally interbred to generate <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP</italic></sup>mice, which are healthy, fertile and have reached maturity.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Generation of a <italic>Gata6 conditional null </italic>allele</bold>. (A) Schematic showing a map of the <italic>Gata6 </italic>genomic locus and the targeting vector with exons represented by open boxes. The relative position of Southern blot probes (lines), PCR primers (small arrowheads), <italic>loxP </italic>(large arrowheads) and FRT (ovals) sites, as well as cassettes encoding neomycin phosphotransferase (neo) and diphtheria toxin (DT), are included. Sizes of relevant <italic>Eco</italic>RI (e), <italic>Nde</italic>I (n), and <italic>Pac</italic>I (p) restriction endonuclease fragments are shown in kilobase pairs (kb). (B) Southern blot analysis of genomic DNA isolated from ES cells (lanes 1, 2, 8 and 9) or mouse tails (lanes 3&#x02013;7 and 10). An example of an ES cell line containing a correctly targeted <italic>Gata6</italic><sup><italic>loxP(FRTneoFRT) </italic></sup>allele is shown in lanes 2 and 8. Mice harbouring the modified <italic>Gata6 </italic>allele were generated from these ES cells (lanes 3 and 10). Exon 2 of <italic>Gata6 </italic>was deleted (<italic>Gata6</italic><sup><italic>del</italic></sup>) or the <italic>neo </italic>cassette alone was deleted, leaving <italic>Gata6 </italic>exon 2 flanked by <italic>lox</italic>P elements (<italic>Gata6</italic><sup><italic>loxP</italic></sup>), by breeding <italic>Gata6</italic><sup><italic>loxP(FRTneoFRT) </italic></sup>mice to transgenic mice expressing either Cre (lane 6 and 7) or Flp (lane 4) recombinases, respectively. The size of restriction fragments identified by 5' and 3' probes (Fig. 1A) was deduced from their position relative to standard DNA fragments. (C) The genotypes of mice and embryos were also determined by PCR amplification of genomic DNA. Primers were designed that differentiated between the <italic>Gata6</italic><sup>+ </sup>(gt4F/4R; 159 bp), <italic>Gata</italic><sup><italic>loxP </italic></sup>(gt4F/4R; 250 bp) and <italic>Gata6</italic><sup><italic>del </italic></sup>(k/o2F/2R; 568 bp) alleles, as well as <italic>neo </italic>(Neo A/B; 225 bp), <italic>flp </italic>(Flp F/R; 750 bp), and <italic>cre </italic>(Cre 1/2; 300 bp) transgenes.</p></caption><graphic xlink:href="1471-213X-6-19-1"/></fig><p>We next addressed whether removal of GATA6 could be induced <italic>in vivo </italic>by expression of Cre recombinase. We chose to disrupt the <italic>Gata6 </italic>gene in the gastrointestinal tract because it is highly expressed in the epithelium and may have roles in controlling gut physiology or development. To produce <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup><italic>Villin-Cre </italic>mice, we bred <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup>mice with transgenic mice (Tg(Vil-cre)997Gum) in which Cre expression was directed to the epithelial cells of the small intestine by the <italic>Villin </italic>(<italic>Vil1</italic>) promoter [<xref ref-type="bibr" rid="B12">12</xref>]. Using this transgenic strain of mice, Cre activity can be detected in the epithelium of the small intestine from E14.5 [<xref ref-type="bibr" rid="B12">12</xref>]. <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup><italic>Villin-Cre </italic>males were mated with <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup>females to obtain <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup><italic>Villin-Cre </italic>control and <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP</italic></sup><italic>Villin-Cre </italic>experimental offspring. In previous experiments, we observed that the efficiency through which Cre mediates recombination between <italic>lox</italic>P sites varies between different transgenic male mice [<xref ref-type="bibr" rid="B13">13</xref>]. We noted a similar situation when using various <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup><italic>Villin-Cre </italic>males. In the majority of cases (4/5 stud males) we were unable to obtain <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP</italic></sup><italic>Villin-Cre </italic>offspring (n = 95 mice genotyped), and this lethality associated with presumptive loss of GATA6 in the intestine is currently under investigation. However, one <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup><italic>Villin-Cre </italic>male did produce offspring (12/90) whose genotype was determined to be <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP</italic></sup><italic>Villin-Cre </italic>by PCR analysis of tail DNA. We, therefore, used RT-PCR with <italic>Gata6 </italic>primers corresponding to nucleotide sequences predicted to be deleted after recombination between <italic>Gata6 lox</italic>P elements, to compare the steady-state levels of <italic>Gata6 </italic>mRNA in intestines isolated from control and experimental mice generated by this particular <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup><italic>Villin-Cre </italic>male. Fig. <xref ref-type="fig" rid="F2">2A</xref> shows that <italic>Gata6 </italic>mRNA could be detected in control intestine but not in intestine isolated from a subset of <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP</italic></sup><italic>Villin-Cre </italic>offspring. The remaining <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP</italic></sup><italic>Villin-Cre </italic>mice were found to continue to express <italic>Gata6 </italic>mRNA at varying levels (data not shown). We also examined expression of GATA6 protein in the intestines of <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP</italic></sup><italic>Villin-Cre </italic>offspring derived from the same Gata6<sup><italic>loxP</italic>/+</sup><italic>Villin-Cre </italic>male. Fig. <xref ref-type="fig" rid="F2">2B</xref> shows that GATA6 was detected as an abundant nuclear protein in the epithelial cells of control intestines. However, <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup><italic>Villin-Cre </italic>mice displayed a marked reduction in the abundance of intestinal GATA6 (Fig. <xref ref-type="fig" rid="F2">2B</xref>). From these results, we conclude that the <italic>Gata6 </italic>gene can be conditionally disrupted in <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup>mice by cell-type specific expression of Cre recombinase.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold><italic>Gata6 </italic>can be successfully ablated in the intestine of <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup>mice by expression of Cre from the <italic>Villin </italic>promoter</bold>. (A) The steady-state level of <italic>Gata6 </italic>mRNA was compared in intestines isolated from four control <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup><italic>Villin-Cre </italic>(lanes 2&#x02013;5) or experimental <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP</italic></sup><italic>Villin-Cre </italic>(lanes 6&#x02013;9) mice. Amplification of Pol2 (<italic>Polr2a</italic>) mRNA showed that similar levels of starting material were utilized in each reaction. (B) Immunohistochemistry showing that GATA6 was detected as an abundant nuclear protein in epithelial cells (arrows) of control intestines, but was detected at greatly reduced levels in <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP</italic></sup><italic>Villin-Cre </italic>intestines.</p></caption><graphic xlink:href="1471-213X-6-19-2"/></fig><p>Cre-mediated deletion of exon2 in <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup>mice was predicted to result in loss of GATA6 function. If this were true, we expected that embryos homozygous for the deleted allele (<italic>Gata6</italic><sup><italic>del</italic></sup>) should undergo developmental arrest, as was described for <italic>Gata6</italic><sup>-/- </sup>embryos [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. <italic>Gata6</italic><sup><italic>del</italic>/+ </sup>mice were produced by mating <italic>Gata6</italic><sup><italic>loxP</italic>(<italic>FRTneoFRT</italic>)/+ </sup>mice with an <italic>EIIa-Cre </italic>transgenic mouse (B6.FVB-Tg(EIIa-cre)C5379Lmgd/J). The <italic>EIIa-Cre </italic>mouse expresses Cre recombinase in nearly all tissues, including those of pre-implantation embryos, and has been used previously to mediate recombination between <italic>lox</italic>P sites in germ cells [<xref ref-type="bibr" rid="B14">14</xref>]. <italic>Gata6</italic><sup>+/<italic>del </italic></sup>progeny were identified by Southern blot analyses of <italic>Nde</italic>I digested tail DNA. As shown in Fig. <xref ref-type="fig" rid="F1">1B</xref>, Southern blots hybridized with the 5' <italic>Gata6 </italic>probe (Fig. <xref ref-type="fig" rid="F1">1A</xref>) revealed the conversion of a 15.2 kb <italic>Nde</italic>I fragment from the <italic>Gata6</italic><sup><italic>loxP</italic>(<italic>FRTneoFRT</italic>) </sup>allele to an expected 12 kb <italic>Nde</italic>I fragment from the <italic>Gata6</italic><sup><italic>del </italic></sup>allele. <italic>Gata6</italic><sup>+/<italic>del </italic></sup>were then mated <italic>inter se</italic>, and the genotype of embryos collected between E8.5 and E11.5 was determined by PCR analysis of genomic DNA. Of 77 embryos recovered, 27 were <italic>Gata6</italic><sup>+/+ </sup>and 50 were <italic>Gata6</italic><sup>+/<italic>del </italic></sup>(Table <xref ref-type="table" rid="T1">1</xref>). In addition, 23 partially resorbed empty decidual masses were recovered, which we believe likely resulted from the early developmental arrest of <italic>Gata6</italic><sup><italic>del</italic>/<italic>del </italic></sup>embryos. We finally determined whether the developmental lethality associated with loss of GATA6 could be induced by expression of Cre in pre-implantation embryos. To achieve this, <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup>mice were bred to <italic>Gata6</italic><sup>+/<italic>del</italic></sup><italic>EIIa-Cre </italic>mice, which are heterozygous for the <italic>EIIa-Cre </italic>transgene. The genotype of resulting embryos ranging from E8.5 to E11.5 was again determined by PCR. While we recovered 14 <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup>, 18 <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>del</italic></sup>, and 16 <italic>Gata6</italic><sup><italic>loxP</italic>/+</sup><italic>EIIaCre </italic>embryos, no <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>del</italic></sup><italic>EIIaCre </italic>embryos were identified although 13 empty resorbing decidual masses were observed (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Embryonic lethality associated with loss of GATA6 function</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" colspan="2"><italic>Gata6</italic><sup>+/<italic>del </italic></sup>X <italic>Gata6</italic><sup>+/<italic>del</italic></sup></td><td align="left" colspan="2"><italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup>X <italic>Gata6</italic><sup>+/<italic>del </italic></sup><italic>EIIa-Cre</italic></td></tr></thead><tbody><tr><td align="left">genotype</td><td align="left">E8.5 &#x02013; 11.5 embryos</td><td align="left">genotype</td><td align="left">E8.5 &#x02013; 11.5 embryos</td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="left"><italic>+/+</italic></td><td align="left">27</td><td align="left"><italic>loxP/+</italic></td><td align="left">14</td></tr><tr><td align="left"><italic>+/del</italic></td><td align="left">50</td><td align="left"><italic>loxP/+ EIIa-Cre</italic></td><td align="left">16</td></tr><tr><td align="left"><italic>del/del</italic></td><td align="left">0</td><td align="left"><italic>loxP/del</italic></td><td align="left">18</td></tr><tr><td align="left">resorbed</td><td align="left">23</td><td align="left"><italic>loxP/del EIIa-Cre</italic></td><td align="left">0</td></tr><tr><td></td><td></td><td align="left">resorbed</td><td align="left">13</td></tr></tbody></table></table-wrap></sec><sec><title>Conclusion</title><p>In summary, we conclude that we have generated a line of mice in which GATA6 transcriptional activity can be ablated by expression of Cre. We believe that the availability of this mouse will be useful to elucidate the contribution of GATA6 during organogenesis as well as its physiological role in adult mice.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Plasmid construction</title><p>A bacterial artificial chromosome (BAC # RP23-410I12) that contained <italic>Gata6 </italic>genomic DNA was obtained from BACPAC Resources, Children Hospital Research Institute, Oakland, CA. Plasmid pNeb-DT-GATA6 was generated by cloning a 12.2 kb EcoRV/PacI genomic fragment containing <italic>Gata6 </italic>exons 1 and 2 into the PacI/HincII site of a vector, pNEB193-DT, which contained a diphtheria toxin (DT) expression cassette to enrich against random integration of the targeting plasmid in ES cells. A cassette containing <italic>loxP-neo-loxP </italic>was amplified by PCR from the plasmid pSV-LNL (modified from Zhang <italic>et al</italic>)[<xref ref-type="bibr" rid="B15">15</xref>] using the following primers: <italic>Gata6ET1:</italic><underline>GCTTGCTGTTTGAGTCTACCCCATTTCTGCCTGTTTCTTGACATCCCTTCGAATT</underline>CTGGTACCGGCGCGCCTAGTCGAC, <italic>Gata6ET2:</italic><underline>ATCCATTATTGTCAATGTCTAAAGATGGAATTGTCTCTGCACAAGCTATCTTCTC</underline>AACTCGAGCCCTTAATTAACCGGT. These oligonucleotides contained 55 bp of sequence from <italic>Gata6 </italic>intron 2 (underlined). This amplicon was introduced into <italic>Gata6 </italic>intron 2 sequence in pNEB-DT-GATA6 by homologous recombination in <italic>E.coli </italic>following the procedure described by <italic>Lee et al </italic>[<xref ref-type="bibr" rid="B8">8</xref>] The <italic>loxPneoloxP </italic>cassette was then converted to a single <italic>lox</italic>P site by expression of Cre recombinase [<xref ref-type="bibr" rid="B8">8</xref>]. A <italic>loxP(FRTneoFRT) </italic>cassette was then amplified from pSV-LFNF using primers <italic>Gata6ET3:</italic><underline>CACGCTGGTGGTTGTAAGGCGGTTTGTGTTTAAGGTGTGCGGTTGGCCTGGACGTG</underline>TGGTACCGGCGCGCCTAGTCGAC, <italic>Gata6ET4:</italic><underline>GAAAAAGTTACCTAGCCCAGAGAAAGTGAGATGCCAGGAAAGGCATAAGGAT</underline>ATCAACTCGAGCCCTTAATTAACCGGT. These oligonucleotides contain 56 bp (Gata6ET3) and 52 bp (Gata6ET4) of sequence from <italic>Gata6 </italic>intron 1, respectively. This cassette was introduced into <italic>Gata6 </italic>intron 1, again using homologous recombination in <italic>E.coli</italic>. to generate the final targeting vector (Fig. <xref ref-type="fig" rid="F1">1A</xref>).</p></sec><sec><title>ES cell targeting and animals</title><p>Linear targeting vector (100&#x003bc;g) was introduced into R1 ES cells by electroporation, and the genotype of colonies resistant to 350&#x003bc;g/ml of Geneticin (Gibco BRL) was determined by Southern blot (Fig. <xref ref-type="fig" rid="F1">1B</xref>). Chimeric mice were generated by aggregation of ES cells with CD-1 morulae as described previously [<xref ref-type="bibr" rid="B10">10</xref>] and the modified allele was passed through the germline by breeding chimeras to CD1 mice. <italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup>mice were produced by breeding <italic>Gata6</italic><sup><italic>loxp</italic>(<italic>FRTneoFRT</italic>)/+ </sup>mice to B6;SJL-Tg(ACTFLPe)9205Dym/J mice [<xref ref-type="bibr" rid="B16">16</xref>] (Jackson Labs) to delete the <italic>FRTneoFRT </italic>cassette by Flp-mediated recombination in the germline. The <italic>ACTFLPe </italic>transgene was removed by breeding F<sub>1 </sub><italic>Gata6</italic><sup><italic>loxP</italic>/<italic>loxP </italic></sup>mice into CD-1 mice. <italic>Gata6</italic><sup>+/<italic>del </italic></sup>mice were generated by mating <italic>Gata6</italic><sup><italic>loxp</italic>(<italic>FRTneoFRT</italic>)</sup>/<sup>+ </sup>animals with B6.FVB-Tg(EIIa-cre)C5379Lmgd/J transgenic mice [<xref ref-type="bibr" rid="B17">17</xref>] (Jackson Labs) to allow Cre-mediate recombination between <italic>lox</italic>P elements in the germline. The <italic>EIIa-Cre </italic>transgene was removed by breeding <italic>Gata6</italic><sup>+/<italic>del </italic></sup>F<sub>1 </sub>mice with CD1 mice. The MCW IACUC committee approved all procedures using animals.</p></sec><sec><title>Southern blot, PCR and RT-PCR</title><p>Southern blot analyses were performed using standard conditions with probes indicated in Fig. <xref ref-type="fig" rid="F1">1</xref>. Genotypes were determined by PCR using the following oligonucleotide primer pairs: <italic>Gata6 gt4F</italic>/4R, GTGGTTGTAAGGCGGTTTGT, ACGCGAGCTCCAGAAAAAGT; <italic>Gata6 k/o</italic>2F/2R, AGTCTCCCTGTCATTCTTCCTGCTC, TGATCAAACCTGGGTCTACACTCCTA; <italic>Flp F/R</italic>, GGTCCAACTGCAGCCCAAGCTTCC, GTGGATCGATCCTACCCCTTGCG [<xref ref-type="bibr" rid="B16">16</xref>]; <italic>Cre 1/2</italic>, GTTCGCAAGAACCTGATGGACA, CTAGAGCCTGTTTTGCACGTTC [<xref ref-type="bibr" rid="B18">18</xref>]; <italic>Neo A/B</italic>, GCCAACGCTATGTCCTGATAGCGGT, AGCCGGTCTTGTCGATCAGGATGAT. RT-PCR was performed as described previously [<xref ref-type="bibr" rid="B19">19</xref>] with the following primer pairs: <italic>Gata6 9/10; </italic>AGTTTTCCGGCAGAGCAGTA, AGTCAAGGCCATCCACTGTC, <italic>Pol2 F/R; </italic>CTGATGCGGGTGCTGAGTGAGAAGG, GCGGTTGACCCCATGACGAGTG.</p></sec></sec><sec><title>Immunohistochemistry</title><p>Immunohistochemistry was performed using antigen retrieval in citrate buffer as described previously [<xref ref-type="bibr" rid="B13">13</xref>] using an anti-GATA6 antibody (AF1700 R&#x00026;D Systems,1/1000 dilution).</p></sec><sec><title>Abbreviations</title><p>Neo, neomycin phosphotransferase</p></sec><sec><title>Authors' contributions</title><p>C.P.S. generated the targeting vector and carried out analyses of conditional knockout mice, as well as contributed to experimental design and draft of the manuscript. J. L. generated aggregation chimeras. S.A.D. conceived of the study, contributed to experimental design and interpretation of results, and coordinated the project and writing of the manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We would like to thank Drs. Robert Burgess and Francis Stewart for providing plasmids and Dr. Neal Copeland for providing bacterial strains used in recombineering. Pregnant mare serum gonadotrophin (PMSG) used in superovulation was obtained from Dr. A.F. Parlow at the National Hormone and Peptide Program (Torrance, CA). We are also grateful to Dr. Michele Battle for critically evaluating the manuscript and for providing plasmids. This work was supported by an NIH training grant from the MCW cardiovascular research centre to C.P.S and NIH grants to S.A.D.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morrisey</surname><given-names>EE</given-names></name><name><surname>Ip</surname><given-names>HS</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Parmacek</surname><given-names>MS</given-names></name></person-group><article-title>GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm</article-title><source>Dev Biol</source><year>1996</year><volume>177</volume><fpage>309</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">8660897</pub-id><pub-id pub-id-type="doi">10.1006/dbio.1996.0165</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morrisey</surname><given-names>EE</given-names></name><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Sigrist</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Jiang</surname><given-names>F</given-names></name><name><surname>Ip</surname><given-names>HS</given-names></name><name><surname>Parmacek</surname><given-names>MS</given-names></name></person-group><article-title>GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo</article-title><source>Genes Dev</source><year>1998</year><volume>12</volume><fpage>3579</fpage><lpage>3590</lpage><pub-id pub-id-type="pmid">9832509</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Watt</surname><given-names>AJ</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Luebke-Wheeler</surname><given-names>J</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name><name><surname>Duncan</surname><given-names>SA</given-names></name></person-group><article-title>GATA6 is essential for embryonic development of the liver but dispensable for early heart formation</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>2622</fpage><lpage>2631</lpage><pub-id pub-id-type="pmid">15767668</pub-id><pub-id pub-id-type="doi">10.1128/MCB.25.7.2622-2631.2005</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laverriere</surname><given-names>AC</given-names></name><name><surname>MacNeill</surname><given-names>C</given-names></name><name><surname>Mueller</surname><given-names>C</given-names></name><name><surname>Poelmann</surname><given-names>RE</given-names></name><name><surname>Burch</surname><given-names>JB</given-names></name><name><surname>Evans</surname><given-names>T</given-names></name></person-group><article-title>GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>23177</fpage><lpage>23184</lpage><pub-id pub-id-type="pmid">8083222</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koutsourakis</surname><given-names>M</given-names></name><name><surname>Langeveld</surname><given-names>A</given-names></name><name><surname>Patient</surname><given-names>R</given-names></name><name><surname>Beddington</surname><given-names>R</given-names></name><name><surname>Grosveld</surname><given-names>F</given-names></name></person-group><article-title>The transcription factor GATA6 is essential for early extraembryonic development</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>723</fpage><lpage>732</lpage></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brewer</surname><given-names>A</given-names></name><name><surname>Gove</surname><given-names>C</given-names></name><name><surname>Davies</surname><given-names>A</given-names></name><name><surname>McNulty</surname><given-names>C</given-names></name><name><surname>Barrow</surname><given-names>D</given-names></name><name><surname>Koutsourakis</surname><given-names>M</given-names></name><name><surname>Farzaneh</surname><given-names>F</given-names></name><name><surname>Pizzey</surname><given-names>J</given-names></name><name><surname>Bomford</surname><given-names>A</given-names></name><name><surname>Patient</surname><given-names>R</given-names></name></person-group><article-title>The human and mouse GATA-6 genes utilize two promoters and two initiation codons</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>38004</fpage><lpage>38016</lpage><pub-id pub-id-type="pmid">10608869</pub-id><pub-id pub-id-type="doi">10.1074/jbc.274.53.38004</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patient</surname><given-names>RK</given-names></name><name><surname>McGhee</surname><given-names>JD</given-names></name></person-group><article-title>The GATA family (vertebrates and invertebrates)</article-title><source>Curr Opin Genet Dev</source><year>2002</year><volume>12</volume><fpage>416</fpage><lpage>422</lpage><pub-id pub-id-type="pmid">12100886</pub-id><pub-id pub-id-type="doi">10.1016/S0959-437X(02)00319-2</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>EC</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Martinez de Velasco</surname><given-names>J</given-names></name><name><surname>Tessarollo</surname><given-names>L</given-names></name><name><surname>Swing</surname><given-names>DA</given-names></name><name><surname>Court</surname><given-names>DL</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name></person-group><article-title>A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA</article-title><source>Genomics</source><year>2001</year><volume>73</volume><fpage>56</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">11352566</pub-id><pub-id pub-id-type="doi">10.1006/geno.2000.6451</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Nagy</surname><given-names>R</given-names></name><name><surname>Abramow-Newerly</surname><given-names>W</given-names></name><name><surname>Roder</surname><given-names>JC</given-names></name></person-group><article-title>Derivation of completely cell culture-derived mice from early-passage embryonic stem cells</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><fpage>8424</fpage><lpage>8428</lpage><pub-id pub-id-type="pmid">8378314</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>SA</given-names></name><name><surname>Allen</surname><given-names>ND</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Auerbach</surname><given-names>A</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name></person-group><article-title>Non-injection methods for the production of embryonic stem cell-embryo chimaeras</article-title><source>Nature</source><year>1993</year><volume>365</volume><fpage>87</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">8361547</pub-id><pub-id pub-id-type="doi">10.1038/365087a0</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>CI</given-names></name><name><surname>Buchholz</surname><given-names>F</given-names></name><name><surname>Galloway</surname><given-names>J</given-names></name><name><surname>Sequerra</surname><given-names>R</given-names></name><name><surname>Kasper</surname><given-names>J</given-names></name><name><surname>Ayala</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>AF</given-names></name><name><surname>Dymecki</surname><given-names>SM</given-names></name></person-group><article-title>High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">10835623</pub-id><pub-id pub-id-type="doi">10.1038/75973</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madison</surname><given-names>BB</given-names></name><name><surname>Dunbar</surname><given-names>L</given-names></name><name><surname>Qiao</surname><given-names>XT</given-names></name><name><surname>Braunstein</surname><given-names>K</given-names></name><name><surname>Braunstein</surname><given-names>E</given-names></name><name><surname>Gumucio</surname><given-names>DL</given-names></name></person-group><article-title>Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>33275</fpage><lpage>33283</lpage><pub-id pub-id-type="pmid">12065599</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M204935200</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parviz</surname><given-names>F</given-names></name><name><surname>Matullo</surname><given-names>C</given-names></name><name><surname>Garrison</surname><given-names>WD</given-names></name><name><surname>Savatski</surname><given-names>L</given-names></name><name><surname>Adamson</surname><given-names>JW</given-names></name><name><surname>Ning</surname><given-names>G</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Rossi</surname><given-names>JM</given-names></name><name><surname>Zaret</surname><given-names>KS</given-names></name><name><surname>Duncan</surname><given-names>SA</given-names></name></person-group><article-title>Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis</article-title><source>Nat Genet</source><year>2003</year><volume>34</volume><fpage>292</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">12808453</pub-id><pub-id pub-id-type="doi">10.1038/ng1175</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lakso</surname><given-names>M</given-names></name><name><surname>Pichel</surname><given-names>JG</given-names></name><name><surname>Gorman</surname><given-names>JR</given-names></name><name><surname>Sauer</surname><given-names>B</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name><name><surname>Westphal</surname><given-names>H</given-names></name></person-group><article-title>Efficient in vivo manipulation of mouse genomic sequences at the zygote stage</article-title><source>Proc Natl Acad Sci U S A</source><year>1996</year><volume>93</volume><fpage>5860</fpage><lpage>5865</lpage><pub-id pub-id-type="pmid">8650183</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.12.5860</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Buchholz</surname><given-names>F</given-names></name><name><surname>Muyrers</surname><given-names>JP</given-names></name><name><surname>Stewart</surname><given-names>AF</given-names></name></person-group><article-title>A new logic for DNA engineering using recombination in Escherichia coli</article-title><source>Nat Genet</source><year>1998</year><volume>20</volume><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">9771703</pub-id><pub-id pub-id-type="doi">10.1038/2417</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dymecki</surname><given-names>SM</given-names></name></person-group><article-title>Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice</article-title><source>Proc Natl Acad Sci U S A</source><year>1996</year><volume>93</volume><fpage>6191</fpage><lpage>6196</lpage><pub-id pub-id-type="pmid">8650242</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.12.6191</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holzenberger</surname><given-names>M</given-names></name><name><surname>Lenzner</surname><given-names>C</given-names></name><name><surname>Leneuve</surname><given-names>P</given-names></name><name><surname>Zaoui</surname><given-names>R</given-names></name><name><surname>Hamard</surname><given-names>G</given-names></name><name><surname>Vaulont</surname><given-names>S</given-names></name><name><surname>Bouc</surname><given-names>YL</given-names></name></person-group><article-title>Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene</article-title><source>Nucleic Acids Res</source><year>2000</year><volume>28</volume><fpage>E92</fpage><pub-id pub-id-type="pmid">11058142</pub-id><pub-id pub-id-type="doi">10.1093/nar/28.21.e92</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Kubalak</surname><given-names>SW</given-names></name><name><surname>Minamisawa</surname><given-names>S</given-names></name><name><surname>Price</surname><given-names>RL</given-names></name><name><surname>Becker</surname><given-names>KD</given-names></name><name><surname>Hickey</surname><given-names>R</given-names></name><name><surname>Ross</surname><given-names>JJ</given-names></name><name><surname>Chien</surname><given-names>KR</given-names></name></person-group><article-title>Selective requirement of myosin light chain 2v in embryonic heart function</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>1252</fpage><lpage>1256</lpage><pub-id pub-id-type="pmid">9422794</pub-id><pub-id pub-id-type="doi">10.1074/jbc.273.2.1252</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ning</surname><given-names>G</given-names></name><name><surname>Duncan</surname><given-names>SA</given-names></name></person-group><article-title>Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>464</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">10691738</pub-id></citation></ref></ref-list></back></article>


